Biocon Stelara Settlement Places Firm Among Earlier US Rivals

Indian Biosimilars Giant Secures Early 2025 Launch Date For Ustekinumab

Jumping Queue Of Arrows
Biocon has jumped ahead of several other biosimilars • Source: Shutterstock

More from Deals

More from Business